• The Effect Of Antidiabetic Agent Glibenclamide And Meltformine On Lipids And Glycated Haemoglobin In Type 2 Diabetes Patient Attending Uith Ilorin

  • CHAPTER THREE -- [Total Page(s) 1]

    Page 1 of 1

    • CHAPTER THREE
      3.1    Material and Method
      3.2 Study Area
      The study was carried out at University of Ilorin Teaching Hospital, Ilorin, Kwara State. The hospital is located at the State capital of Ilorin, Kwara State Nigeria. It is a referral center to other public and private hospitals within and outside the state.
      3.3    SAMPLE SIZE DETERMINATION
      There was a random selection of ninety (90) subjects, 60 were type 2 Diabetes mellitus individual using either one or combine antidiabetic agent (glibenclamide and meltformine) and 30 subjects (control) with normal fasting blood glucose in this retrospective study.
       3.4   COLLECTION OF SAMPLE
      Full demographic and medical history were collected from all subjects including age, smoking habit, duration of diabetes, type of treatment, and complications. All patients underwent a complete physical examination including measurement of height, weight, waist circumference (WC), and body mass index (BMI, kg/m2) was calculated. From each subject, 10 mL fasting venous blood was collected by vein puncture, using 10ml disposable syringes. The blood sample was divided into two   aliquots; 4 and 6 ml respectively. The first aliquot of 4ml blood was dispensed in a tube containing Ethylene Diamine Tetra acetic acid (EDTA) for glycated hemoglobin (HbA1c) estimation, while the second aliquot of 6ml was dispensed in a plain tube and left to clot at room temperature (25 °C). It was then separated by centrifuge at (3000 rpm) for (10min) to collect serum and stored in the deep freezer (-20 0 C) until the assay day.
      Subjects with renal failure, cushing syndrome or with ascites due to any reason were excluded. Patients with secondary hypertension, hepatobilliary disease and hypothyroidism were as well excluded from the study after thorough clinical evaluation and patients taking drugs that may affect the results of the study such as hypolipidemic agents were excluded.
      3.5 MEASUREMENT OF VARIABLES
      Estimation of the concentration of glycated haemoglobin, Total cholesterol, Triglycerdes, HDL-Cholesterol using spectrophometery method and calculation of LDL-cholesterol by ferdwald formula. The parameters measured by enzymatic methods: glucose kit supplied by Spinreact, Spain, Glucose-6-phophatase Enzyme from Cusabio, Chinam, Glycated haemoglobin (GHb) from Infopia, Korea, HDL-Cholesterol, Total Cholesterol and Triglyceride from Randox, U.K.
      3.6 STATISTICAL ANALYSIS
      The data obtained from the study will be inputted into computer and analyzed using the statistical package for Social Sciences (SPSS). The data will be presented in table, pie chart, histogram and subjected to ANOVA, chi-square test and student T-test. P<0.05 will be considered significant at 95% confidence level.
      3.7 ETHICAL CONSIDERATION AND INFORMED CONSENT
      Approval for the study will obtained from the Health Research Committee of Kwara State. The participants will be informed on the objectives, benefits and procedure of the study will be explained to them and they will be assured of the confidentiality of the information provided. Each voluntary participant will be identified with unique number. A written informed consent through questionnaire will be obtained from each of the participant before enrolment into the study.

  • CHAPTER THREE -- [Total Page(s) 1]

    Page 1 of 1

    • ABSRACT - [ Total Page(s): 1 ]Abstract Is Coming Soon ... Continue reading---

         

      APPENDIX A - [ Total Page(s): 1 ]APPENDIX IQUESTIONAIRE TO ACCESS THE ANTHROPOLOGIC INDICES OF PATIENTS WITH TYPE TWO DIABETES MELLITUS ON ANTIDIABETIC DRUGS (METFORMIN AND GLIBENCLAMIDE) ATTENDING UITH ILORIN.INTRODUCTION: I am a final year students of the Department of Medical Laboratory Science, School of Basic Medical Sciences, Kwara State University, Malete, Kwara State. This questionnaire is aimed at accessing the demographic indices of patients with type 2 Diabetes mellitus on metformin and diabinese in Ilorin metropolis ... Continue reading---

         

      APPENDIX B - [ Total Page(s): 5 ]Step 2100µl of the supernatant was dispensed into the clean test tubes respectively.2ml of the cholesterol reagent was addedIt was incubated at room temperature for 10minsAbsorbance of sample against reagent blank was measured at 505nmGlycated HaemoglobinGlycated Haemoglobin is a form of haemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average.ProcedureReagentsBlank(µl)             samp ... Continue reading---

         

      CHAPTER ONE - [ Total Page(s): 2 ]The present study was designed to investigate and compare the effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients.1.2    STATEMENT OF PROBLEMTo know if antidiabetic agents glibenclamide and meltformine has any effect on lipid and glycated haemoglobin in type 2 diabetes patients1.3     AIM OF STUDYTo evaluate the effect of antidiabetic agent glibenclamide and meltformine on lipids and glycated haemoglobin in type 2 diabetes patient attendi ... Continue reading---

         

      CHAPTER TWO - [ Total Page(s): 11 ]Triglycerides as major components of very low-density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice as much energy (approximately 9kcal/g or 38kj/g) as carbohydrates (approximately 4kcal/g or 17kj/g) (Brefere et al., 2014).2.5 Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also referred to as being Hb1c or HGBA1C) is a form of hemoglobin that is measured primarily to i ... Continue reading---

         

      CHAPTER FOUR - [ Total Page(s): 4 ]Tables 4.6: Correlation of Duration in Diabetes and BMI with biochemical parameters (T. cholesterol, High Density Lipoprotein, Low Density Lipoprotein, triglycerides, glycated, and fasting blood sugar) in Diabetic patient using antidiabetic drugs (Metformin and Glianpride). ... Continue reading---

         

      CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DISCUSSIONThe study shows discrepant results about the influence of metformin on lipid profile (10). Some studies, in agreement with ours, reported reduction only in TC levels (Grant, 1996; Ginsberg et al., 1999), while others reported reduction of TC and TG with an increase of HDL-C (Robinson et al., 1998; Yki-Jarvinen et al., 1999). Still other studies showed no changes in lipid profile (Groop et al., 1998; Rains et al., 1998). Another investigation showed an association of met ... Continue reading---

         

      REFRENCES - [ Total Page(s): 3 ]Rodger, W. (2012). Sulphonylureas and heart disease in diabetes management. Diabetes Spectrum. Pg. 12–27.Rosenbaum, M. and Leibel, R. L. (2014). Role of leptin in energy homeostasis in humans. Journal of Endocrinology. 223(1): 83-96.Rowley, D.E. and Bezold, D.C. (2012). Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. Journal of American Medical Association. Pg. 289.Shaw, D., De Rosa, N. and Di Maro, G. (2010). Metformin improves glucose, lipid ... Continue reading---